Imageens
Imageens develops AI-based clinical decision software and proprietary technology for cardiovascular imaging analysis. Its primary product, ArtFun+, is a CE-marked medical device that measures MRI-based biomarkers of arterial stiffness to predict cardiovascular risk and detect early vascular aging. The company serves clinical centers and research institutions by providing tools for cardiovascular risk stratification and monitoring.
Healthtech
Medical Devices
Artificial Intelligence
Cardiovascular Health
Funding summary
- Total raised
- €1.2M
- Funding rounds
- 1
Investors in Imageens
Investors on record for Imageens. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Imageens?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors